A unique model
IRIC, located in the heart of the Université de Montréal campus, operates according to a unique model in Canada that combines, under one roof, fundamental research activities, a university-level training program and a research maturation team. These generate discoveries that advance knowledge or that can quickly translate into new therapeutic solutions.
-
![]()
News 2026 Student Recruitment Event: Meet the scientific talents of tomorrow!
Each year, the IRIC Student Recruitment Event offers students interested in pursuing graduate studies in cancer research a unique opportunity to participate in an international recruitment event at the Institute for Research in Immunology and Cancer at the University of Montreal.
-
![]()
News More than $1 million in grant for Michel Bouvier and the startup Drave Therapeutics
The team of Michel Bouvier, director of IRIC’s Molecular Pharmacology Research Unit, receives $1,08 M for a project in precision pharmacology of G protein-coupled receptors (GPCR). This grant is supported by the Consortium québécois sur la découverte du médicament (CQDM), through the Ministère de l’Économie, de l’Innovation et de l’Énergie du Québec, and by the co-funding partners Drave Therapeutics and the Université de Montréal.
-
![]()
News Claude Perreault Named Knight of the Ordre national du Québec
On June 17, Professor Claude Perreault, director of IRIC’s Immunobiology Research Unit, will be awarded the title of Knight of the Ordre national du Québec.
-
![]()
News A “super-skeleton” that transmits mechanical forces to the cell surface
The team led by Gregory Emery, director of IRIC’s Vesicular Trafficking and Cell Signalling Research Unit, has identified a dynamic structure that forms a network on the surface of epithelial cells. The work, led by PhD students Claire Baudouin and Léa Marpeaux, is the subject of a publication in the Journal of Cell Science. The article made the journal’s cover and is accompanied by an interview with the two students.
-
![]()
News Meet Marie-Anne Goyette, IRIC’s new principal investigator!
IRIC is proud to announce the arrival of Marie-Anne Goyette as the new Principal Investigator in Tumor Heterogeneity and Metastasis Research Unit. Marie-Anne Goyette has kindly agreed to answer a few questions.
-
![]()
News IRIC’s Gala Audace: $1,130,000 Raised for Cancer Research
On May 21, the 2026 edition of the Gala Audace, hosted by the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal, took place. Thanks to the generosity of more than 300 guests gathered at Marché Bonsecours, our valued donors, and our sponsors, a remarkable sum of $1,130,000 was raised to support cancer research at IRIC.
